Related Experiment Video
Updated: Mar 16, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
Tjalf Ziemssen1, Raimar Kern2, Katja Thomas2
1MS Center Dresden, Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstr 74, 01307, Dresden, Germany. Tjalf.Ziemssen@uniklinikum-dresden.de.
Multiple sclerosis (MS) is a complex disease requiring detailed clinical profiling and patient-reported outcomes for effective long-term management. Advanced computational analysis of biological data is essential for personalizing MS treatments.
Area of Science:
- Neurology
- Immunology
- Computational Biology
Background:
- Multiple sclerosis (MS) exhibits significant inter- and intra-individual heterogeneity in disease presentation and progression.
- Current MS patient profiling relies on immunological, genetic, and MRI data, but clinical characterization needs enhancement.
- Integrating patient-reported outcomes is crucial for comprehensive clinical profiling in MS.
Purpose of the Study:
- To emphasize the necessity of standardized and comprehensive clinical profiling for effective long-term Multiple Sclerosis management.
- To highlight the role of real-world data collection through registries and software in understanding MS.
- To underscore the potential of computational analysis in advancing personalized MS treatment strategies.
Main Methods:
- Implementing a high standard of clinical characterization for individual MS patients.
- Collecting individual clinical data via MS registries and specialized software (e.g., Multiple Sclerosis Documentation System 3D).
- Utilizing computational analysis of biological processes for data interpretation.
Main Results:
- Enhanced clinical profiling provides a foundation for effective long-term observation and evaluation of MS.
- Reliable real-world data can be generated through systematic data collection in MS registries.
- Computational analysis holds promise for processing complex biological information.
Conclusions:
- Comprehensive clinical characterization is key to managing the heterogeneous nature of Multiple Sclerosis.
- The integration of patient-reported outcomes and advanced data collection methods is vital for MS research.
- Bioinformatics and computational systems biology advancements are critical for achieving personalized MS treatment.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets